Clinical Questions #6. Does celecoxib increase cardiovascular risk?
Mayer
Brian J
BJ
University of Wisconsin Hospital and Clinics, USA.
Lamfers
Randall
R
Feldstein
David A
DA
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D000068579:Celecoxib; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy; D039781:PubMed; D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use
D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib